HomeELVN • NASDAQ
add
Enliven Therapeutics Inc
Previous close
$21.74
Day range
$21.33 - $22.41
Year range
$11.02 - $30.01
Market cap
1.09B USD
Avg Volume
190.22K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 27.07M | 17.95% |
Net income | -23.16M | -11.49% |
Net profit margin | — | — |
Earnings per share | -0.48 | — |
EBITDA | -26.99M | -18.01% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 291.83M | 10.76% |
Total assets | 305.43M | 11.45% |
Total liabilities | 17.03M | 38.51% |
Total equity | 288.40M | — |
Shares outstanding | 48.86M | — |
Price to book | 3.56 | — |
Return on assets | -21.40% | — |
Return on capital | -22.80% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2024info | Y/Y change |
|---|---|---|
Net income | -23.16M | -11.49% |
Cash from operations | -12.19M | 23.29% |
Cash from investing | 14.83M | 141.71% |
Cash from financing | 1.12M | 362.82% |
Net change in cash | 3.75M | 107.23% |
Free cash flow | -16.10M | -148.95% |
About
Founded
2016
Headquarters
Website
Employees
57
